DHX33-DT

Across TCGA pan-cancer cohorts, DHX33-DT RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of DHX33-DT’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where DHX33-DT RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DHX33-DT is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

UCEC and KIRC are the cancer types where DHX33-DT tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DHX33-DT RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	III,IV	+0.155	.034	2	view →
KIRC	Male	All	−0.036	.037	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

DHX33-DT–UCEC

Open the UCEC breakdown →